Salud financiera de hoja de balance de Quantum BioPharma
Salud financiera controles de criterios 5/6
Quantum BioPharma has a total shareholder equity of $10.2M and total debt of $615.6K, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are $15.2M and $5.0M respectively.
Información clave
6.0%
Ratio deuda-patrimonio
US$615.56k
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$3.33m |
| Patrimonio | US$10.20m |
| Total pasivo | US$5.04m |
| Activos totales | US$15.25m |
Actualizaciones recientes sobre salud financiera
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 0K91's short term assets ($10.0M) exceed its short term liabilities ($5.0M).
Pasivo a largo plazo: 0K91 has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: 0K91 has more cash than its total debt.
Reducción de la deuda: 0K91's debt to equity ratio has increased from 2.9% to 6% over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 0K91 has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Pronóstico de cash runway: 0K91 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.